Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech ...

AHIP executives discussed the impact the proposed budget bill could have on Medicaid and the individual market.

The Supreme Court upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded ...

Over the past couple of years, ambient scribes have earned widespread adoption among health systems. While there's excitement ...

In the U.S., veterans are 1.5 times more likely to die by suicide than nonveteran adults. Research shows that there were on average 17.5 veteran suicides per day in 2021, the latest year that data ...

Amazon Pharmacy is the second third-party dispensing provider for LillyDirect Pharmacy Solutions, following Truepill. To receive home delivery services for certain Lilly medications, patients ask ...

California’s SB553, the nation’s first comprehensive and multi-industry workplace violence prevention law, has been in effect for almost a year.

The reintroduction of the "Improving Seniors' Timely Access to Care Act" marks a critical step toward modernizing the prior authorization process within Medicare Advantage plans.

Alumis’s lead drug candidate blocks TYK2, an inflammation target that’s already addressed by Sotyktu, a Bristol Myers Squibb drug approved for plaque psoriasis.

Business banking provider* Mercury sponsored a webinar discussing early stage investment topics with venture capitalists such as grant funding secrets, capital valuation, the role of AI in life ...

Verdiva Bio’s once-a-week oral GLP-1 drug is ready for Phase 2 testing. The drug, made with a proprietary technology that enables oral dosing, was licensed from Sciwind Biosciences.

While fibrates are proven to lower triglyceride levels, which can serve as a biomarker for cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a ...